State UT
Clinical Trials in Utah
Utah is home to a significant concentration of clinical research activity, with academic medical centers, community hospitals, and specialized research clinics serving as active trial sites across a broad range of medical conditions. The studies listed here have at least one enrolled site in Utah and represent Phase 1 through Phase 4 research sponsored by NIH, pharmaceutical companies, device manufacturers, and independent investigators.
Right now ClinicalMetric tracks 187 actively recruiting studies with Utah sites out of 187 registered in total. The busiest research areas in Utah are Multiple Myeloma, Heart Failure, Non-small Cell Lung Cancer. Leading sponsors running trials in the state include University of Utah, AstraZeneca, National Cancer Institute (NCI). By stage, Utah trials break down as Phase 1 (41), Phase 2 (58), Phase 3 (49), Phase 4 (2).
All trial data is sourced directly from ClinicalTrials.gov and updated daily. Recruiting status, eligibility criteria, enrollment targets, and contact information are included for each study. Patients and caregivers should review the full eligibility criteria on each trial listing — or consult their treating physician — before contacting a study site.
Top Conditions in Utah
Frequently Asked Questions — Clinical Trials in Utah
How many clinical trials are currently recruiting in Utah?
ClinicalMetric currently tracks 187 actively recruiting clinical trials with at least one location in Utah. The total number of registered studies—including active but not currently enrolling trials—is 187. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in Utah?
Utah hosts clinical trials across a broad range of medical conditions, including Multiple Myeloma, Heart Failure, Non-small Cell Lung Cancer, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Utah serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in Utah?
To join a clinical trial in Utah, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Utah maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.
Recruiting Trials in Utah
NCT06961955 Phase 2
Recruiting
5 vs. 9-day Course of Whole Breast Radiotherapy With Boost for Early-stage Breas...
Condition
Breast Cancer
Enrollment
144 pts
Location
United States
Sponsor
University of Utah
NCT07020117 Phase 1
Recruiting
A Study of [225Ac]Ac-AKY-1189 in Patients With Solid Tumors
Condition
Urothelial Carcinoma Bladder
Enrollment
150 pts
Location
United States
Sponsor
Aktis Oncology, Inc.
NCT06965504 N/A
Recruiting
INitiation and Titration of Guideline Directed Medical TheRApy in HearT Failure ...
Condition
Heart Failure
Enrollment
250 pts
Location
United States
Sponsor
Abiomed Inc.
NCT00009633 N/A
Recruiting
Follow-up Visit of High Risk Infants
Condition
Infant, Newborn
Enrollment
68,000 pts
Location
United States
Sponsor
NICHD Neonatal Research Networ
NCT06192576 N/A
Recruiting
A Real-world Long-term Safety and Immunogenicity Study of Olipudase Alfa Therapy...
Condition
Niemann-Pick Diseases
Enrollment
10 pts
Location
United States
Sponsor
Sanofi
NCT06628908 Phase 3
Recruiting
Evaluation of Efficacy and Safety of Suzetrigine for Pain Associated With Diabet...
Condition
Diabetic Peripheral Neuropathic Pain
Enrollment
1,100 pts
Location
United States
Sponsor
Vertex Pharmaceuticals Incorpo
NCT06941415 Phase 3
Recruiting
Bumetanide vs. Furosemide in Cirrhosis
Condition
Cirrhosis
Enrollment
500 pts
Location
United States
Sponsor
Stacy Johnson
NCT07082868 Phase 1
Recruiting
A Study of Epcoritamab and Ibrutinib in People With Central Nervous System Lymph...
Condition
Primary Central Nervous System Lymphoma (PCNSL)
Enrollment
26 pts
Location
United States
Sponsor
Memorial Sloan Kettering Cance
NCT04649242 Phase 3
Recruiting
Randomized Study in Children and Adolescents With Migraine: Acute Treatment
Condition
Pediatric Migraine
Enrollment
2,100 pts
Location
United States, Canada, China
Sponsor
Pfizer
NCT06270316 Phase 1, Phase 2
Recruiting
Safety, PK/PD, and Exploratory Efficacy Study of AMT-191 in Classic Fabry Diseas...
Condition
Fabry Disease
Enrollment
20 pts
Location
United States
Sponsor
UniQure Biopharma B.V.
NCT04181138 N/A
Recruiting
Primary Sclerosing Cholangitis in Children
Condition
Primary Sclerosing Cholangitis
Enrollment
1,000 pts
Location
United States, Canada
Sponsor
Arbor Research Collaborative f
NCT05911568 N/A
Recruiting
Treatment With Endovascular Intervention for STroke Patients With Existing Disab...
Condition
Stroke
Enrollment
1,060 pts
Location
United States
Sponsor
University of Cincinnati
NCT07630974 Phase 1, Phase 2
Recruiting
A Study of Ifinatamab Deruxtecan in Pediatric Participants With Relapsed or Refr...
Condition
Malignant Neoplasm
Enrollment
134 pts
Location
United States, Australia, Belgium
Sponsor
Merck Sharp & Dohme LLC
NCT06475989 Phase 3
Recruiting
Study of Targeted Therapy vs. Chemotherapy in Patients With Thyroid Cancer
Condition
Refractory Differentiated Thyroid Gland Carcinoma
Enrollment
264 pts
Location
United States
Sponsor
ECOG-ACRIN Cancer Research Gro
NCT04416191 N/A
Recruiting
Immune Cells During Disuse and Recovery
Condition
Muscle Disuse
Enrollment
45 pts
Location
United States
Sponsor
University of Utah
NCT07586917 N/A
Recruiting
Optimizing Pregnancy and Treatment Interventions for Moms 3.0
Condition
Opioid Abuse (Disorder)
Enrollment
429 pts
Location
United States
Sponsor
University of Utah
NCT07114874 Phase 3
Recruiting
NBI-1117568-SCZ3032: Long-Term Evaluation of NBI-1117568 in Adults With Schizoph...
Condition
Schizophrenia
Enrollment
600 pts
Location
United States, Bulgaria, Puerto Rico
Sponsor
Neurocrine Biosciences
NCT06608823 N/A
Recruiting
ARTIST: Aortic Regurgitation Trial Investigating Surgery Versus Trilogy™
Condition
Aortic Regurgitation
Enrollment
1,016 pts
Location
United States
Sponsor
JenaValve Technology, Inc.
NCT07227246 Phase 3
Recruiting
Recombinant Factor VIIa (rFVIIa) for Hemorrhagic Stroke Trial - Part 2
Condition
Intracerebral Hemorrhage
Enrollment
350 pts
Location
United States, Canada, Germany
Sponsor
Joseph Broderick, MD
NCT07044635 Phase 2
Recruiting
Shortened Course of Radiation Therapy After Trans-oral Robotic Surgery in Patien...
Condition
Oropharyngeal Squamous Cell Carcinoma
Enrollment
42 pts
Location
United States
Sponsor
University of Utah
NCT07225023 N/A
Recruiting
A Multi-Site Feasibility Trial of Embedded Emergency Department Physical Therapy...
Condition
Dizziness
Enrollment
100 pts
Location
United States
Sponsor
Northwestern University
NCT05589714 N/A
Recruiting
Universal Rare Gene Study: A Registry and Natural History Study of Retinal Dystr...
Condition
Inherited Retinal Degeneration
Enrollment
1,500 pts
Location
United States, Australia, Belgium
Sponsor
Jaeb Center for Health Researc
NCT06328608 Phase 2, Phase 3
Recruiting
A Study to Learn About the Safety and Effects of the Study Drug PRX-102 in Child...
Condition
Fabry Disease
Enrollment
22 pts
Location
United States, Austria, France
Sponsor
Chiesi Farmaceutici S.p.A.
NCT06131840 Phase 1
Recruiting
A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors
Condition
Colorectal Neoplasms
Enrollment
914 pts
Location
United States, Canada, China
Sponsor
Seagen, a wholly owned subsidi
NCT07582016 N/A
Recruiting
Partnership to Reduce Obesity in Community Health Center Patients (SMARTLife Uta...
Condition
Obesity
Enrollment
5,354 pts
Location
United States
Sponsor
University of Utah
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: November 2026 · Data Methodology